Calcipotriol Plus Hydrocortisone in Paediatric Patients (Aged 6 to 17 Years) With Psoriasis Vulgaris on the Face and on the Intertriginous Areas.

Trial Profile

Calcipotriol Plus Hydrocortisone in Paediatric Patients (Aged 6 to 17 Years) With Psoriasis Vulgaris on the Face and on the Intertriginous Areas.

Completed
Phase of Trial: Phase III

Latest Information Update: 25 Oct 2013

At a glance

  • Drugs Calcipotriol/hydrocortisone (Primary) ; Hydrocortisone (Primary)
  • Indications Plaque psoriasis
  • Focus Therapeutic Use
  • Most Recent Events

    • 03 Jul 2012 Additional trial location (Germany) added as reported by European Clinical Trials Database record.
    • 06 Dec 2010 Actual end date (Dec 2010) added as reported by ClinicalTrials.gov.
    • 06 Dec 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top